International Journal of Clinical Pharmacology and Therapeutics · 2013 · 16 citations · 0 references
Patients treated with FPNS will be unaffected by the development of allergic rhinitis; but, if oxymetazoline is prescribed, the patient would benefit from added supervision when oxymetazoline is started and stopped.